Factors predicting for patient refusal of head and neck cancer therapy

Background The purpose of this study was to evaluate the national rate of treatment refusal in head and neck cancer (HNC). Methods The National Cancer Database was queried for nonmetastatic squamous cell carcinoma of the head and neck. Oncologic therapy referred to receipt of surgery, radiotherapy,...

Full description

Saved in:
Bibliographic Details
Published in:Head & neck 2020-01, Vol.42 (1), p.33-42
Main Authors: Amini, Arya, Verma, Vivek, Li, Richard, Vora, Nayana, Kang, Robert, Gernon, Thomas J., Chang, Sue, Karam, Sana, Massarelli, Erminia, Maghami, Ellie G., Glaser, Scott
Format: Article
Language:English
Subjects:
Cancer therapies
Chemotherapy
definitive treatment
Head & neck cancer
head and neck cancer
Patients
radiation
Radiation therapy
radiotherapy
socioeconomic factors
Squamous cell carcinoma
Surgery
treatment refusal
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The purpose of this study was to evaluate the national rate of treatment refusal in head and neck cancer (HNC). Methods The National Cancer Database was queried for nonmetastatic squamous cell carcinoma of the head and neck. Oncologic therapy referred to receipt of surgery, radiotherapy, or chemotherapy. Results Compared to the 230 424 patients who received treatment, 2965 (1.3%) were reported to have refused definitive therapy. Predictors included older age, female sex, African‐American/other race, nonprivate insurance, greater comorbidities, more advanced disease, and residence closer to the treating facility (P
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.25966